Results 21 to 30 of about 5,870,697 (401)

Relief of Biofilm Hypoxia Using an Oxygen Nanocarrier: A New Paradigm for Enhanced Antibiotic Therapy

open access: yesAdvancement of science, 2020
Biofilms are chief culprits of most intractable infections and pose great threats to human health. Conventional antibiotic therapies are hypodynamic to biofilms due to their strong drug resistance, closely related with biofilm hypoxia. A new strategy for
Dengfeng Hu   +7 more
semanticscholar   +1 more source

Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy

open access: yesInternational Journal of Molecular Sciences, 2020
Helicobacter pylori is a well-known pathogen that is highly prevalent in the world population, and H. pylori infection is potentially hazardous to humans because of its relationship to various gastrointestinal diseases, such as gastric ulcers, chronic ...
Jianfu Ji, Hong Yang
semanticscholar   +1 more source

Antibiotic associated diarrhea in outpatient pediatric antibiotic therapy

open access: yesBMC Pediatrics, 2023
Background Antibiotic-associated diarrhea is one of the most frequent side effects of antimicrobial therapy. We assessed the epidemiological data of antibiotic-associated diarrhea in pediatric patients in our region.
Sevgen Tanır Basaranoğlu   +39 more
doaj   +1 more source

Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review

open access: yesMicroorganisms, 2020
Antimicrobial resistance is a major concern. Epidemiological studies have demonstrated direct relationships between antibiotic consumption and emergence/dissemination of resistant strains.
B. Pilmis, A. Le Monnier, J. Zahar
semanticscholar   +1 more source

The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model

open access: yesBMC Microbiology, 2018
Background Phage therapy is the therapeutic use of bacteriophages to treat highly drug resistant bacterial infections. The current surge in bacteriophage therapy is motivated mainly because of the emergence of antibiotic-resistant bacteria in clinics ...
Prasanth Manohar   +2 more
doaj   +1 more source

The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey [PDF]

open access: yes, 2015
Background The spread of multi-resistant infections represents a continuously growing problem in cirrhosis,particularly in patients in contact with the healthcare environment.
Ceccarelli, Giancarlo   +10 more
core   +2 more sources

74. Empiric Antibiotic Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

open access: yes, 2020
Background: Antibiotic therapy has no known benefit against COVID-19, but is often initiated out of concern for concomitant bacterial infection We sought to determine how common early empiric antibiotic therapy and community-onset bacterial co-infections
Valerie M. Vaughn   +9 more
semanticscholar   +1 more source

Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species

open access: yesFrontiers in Microbiology, 2019
Infections due to antibiotic resistant bacteria are increasing globally and this needs immediate attention. Bacteriophages are considered an effective alternative for the treatment of bacterial infections.
Prasanth Manohar   +4 more
doaj   +1 more source

Care Plan for Community-Acquired Pneumonia

open access: yesCanadian Journal of Infectious Diseases, 2000
This paper presents a critical pathway for the treatment of pneumonia that has been shown to be effective in a randomized clinical trial. The pathway uses a pneumonia-specific severity of illness score to guide the admission decision.
Thomas Marrie   +1 more
doaj   +1 more source

Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) [PDF]

open access: yes, 2014
Bacterial prostatitis (BP) is a common condition accounting responsible for about 5-10% of all prostatitis cases; chronic bacterial prostatitis (CBP) classified as type II, are less common but is a condition that significantly hampers the quality of life,
D. V. Matei   +8 more
core   +4 more sources

Home - About - Disclaimer - Privacy